Avanos Medical (AVNS) Non-Current Deferred Tax Liability (2014 - 2026)

Avanos Medical has reported Non-Current Deferred Tax Liability for 13 years, with the latest figure at $5.6 million in Q1 2026.

• Quarterly Non-Current Deferred Tax Liability changed 0.0% year-over-year to $5.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $5.6 million (changed 0.0% YoY) and the FY2025 annual result came in at $6.1 million, up 10.91% from the prior year.
• Non-Current Deferred Tax Liability declined to $5.6 million in Q1 2026 per AVNS's latest filing, from $6.1 million in the prior quarter.
• Over five years, Non-Current Deferred Tax Liability peaked at $37.0 million in Q3 2022 and troughed at $5.5 million in Q4 2024.
• A 5-year average of $19.9 million and a median of $23.6 million in 2024 frame the typical range for Non-Current Deferred Tax Liability.
• The sharpest annual moves came in 2022 and 2024: Non-Current Deferred Tax Liability jumped 560.71% in 2022, then plunged 76.89% in 2024.
• Over 5 years, Non-Current Deferred Tax Liability stood at $25.4 million in 2022, then decreased by 6.3% to $23.8 million in 2023, then tumbled by 76.89% to $5.5 million in 2024, then climbed by 10.91% to $6.1 million in 2025, then slipped by 8.2% to $5.6 million in 2026.
• According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods registered $5.6 million, $6.1 million, and $6.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.